FundedIQ
Artificial Intelligence

Recursion Pharmaceuticals: Funding, Investors & Team (Sep 2026)

www.recursion.com LinkedIn Salt Lake City, United States 251-500 employees
Artificial Intelligence Biotechnology Machine Learning Pharmaceutical Therapeutics B2B
Total raised
$150M
Rounds
1
Latest
Post-IPO Equity
Oct 2022

Recursion Pharmaceuticals has raised $150M across 1 funding round on record, the most recent a Post-IPO Equity of $150M announced in Oct 2022.

That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Recursion Pharmaceuticals Company Profile and Key Stats

Total funding raised
$150M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Equity
$150M in Oct 2022
Employees
251-500
reported band
Headquarters
Salt Lake City, United States

Latest funding round on record: Oct 2022.

Recursion Pharmaceuticals Funding Rounds

Date
Round
Amount
Post-IPO Equity
$150M

Recursion Pharmaceuticals Founders and Leadership Team

Name
Role
Contact
Blake Borgeson
Founder

No contact details are on record for this team yet.

Recursion Pharmaceuticals Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round

Recursion Pharmaceuticals' latest round of $150M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Recursion Pharmaceuticals in Artificial Intelligence and Salt Lake City

Companies Similar to Recursion Pharmaceuticals

Series A $20.0M

Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…

Series E $156M

Instinct is an artificial intelligence startup developing AI technology.

Series B $250M

Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…

Undisclosed round $15.0M

Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…

Series A $8.0M

Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…

Series A $150M

Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…

Series D $200M

Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…

Series B $200M

Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…

Series A $40.0M

Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…

Undisclosed round $26.1M

Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…

Series A $13.0M

Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…

Series C

Recursion Pharmaceuticals Funding FAQs

How much funding has Recursion Pharmaceuticals raised?

Recursion Pharmaceuticals has raised $150M across 1 round on record. The most recent is a Post-IPO Equity of $150M announced in Oct 2022.

When did Recursion Pharmaceuticals last raise funding?

Recursion Pharmaceuticals' most recent funding round on record is a Post-IPO Equity of $150M, announced in Oct 2022.

Who founded Recursion Pharmaceuticals?

FundedIQ lists Blake Borgeson (Founder) at Recursion Pharmaceuticals.

Where is Recursion Pharmaceuticals headquartered?

Recursion Pharmaceuticals is based in Salt Lake City, Utah, United States.

How many employees does Recursion Pharmaceuticals have?

Recursion Pharmaceuticals is in the 251-500 employee band.

How does Recursion Pharmaceuticals' funding compare to other Artificial Intelligence startups?

Recursion Pharmaceuticals' latest round of $150M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Recursion Pharmaceuticals Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Recursion Pharmaceuticals is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.